IFNG and Guillain-Barre syndrome: Additionally, they presented a comprehensive overview of the current understanding regarding the inflammatory and immunoregulatory role of IFN-γ in GBS and experimental autoimmune neuritis (EAN), indicating that targeting IFN-γ could be an underlying therapeutic strategy for GBS (35).